Template:Myeloid malignancy: Difference between revisions
From WikiMD's Wellness Encyclopedia
en>Andrybak categorization (via WP:JWB) |
m 1 revision imported |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
| name = Myeloid malignancy | | name = Myeloid malignancy | ||
| state = {{{state<includeonly>|autocollapse</includeonly>}}} | | state = {{{state<includeonly>|autocollapse</includeonly>}}} | ||
| title = [[Myeloid]]-related [[ | | title = [[Myeloid]]-related [[hematological malignancy]] | ||
| listclass = hlist | | listclass = hlist | ||
| Line 15: | Line 16: | ||
| list1 = {{Navbox|child | | list1 = {{Navbox|child | ||
| group1 = {{nobold|''[[Acute myeloid leukemia|AML]]''}} | | group1 = {{nobold|''[[Acute myeloid leukemia|AML]]:''}} | ||
| list1 = | | list1 = | ||
* [[Acute myeloblastic leukemia]] | * [[Acute myeloblastic leukemia]] | ||
| Line 98: | Line 99: | ||
| group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}} | | group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}} | ||
| list2 = | | list2 = | ||
* [[Essential | * [[Essential thrombocytosis]] | ||
* [[Acute megakaryoblastic leukemia]] | * [[Acute megakaryoblastic leukemia]] | ||
}} | }} | ||
| Line 113: | Line 115: | ||
| group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}} | | group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}} | ||
| list2 = | | list2 = | ||
* [[ | * [[Polycythemia vera]] | ||
| group3 = {{nobold|''[[Myelodysplastic syndrome|MD]]''}} | | group3 = {{nobold|''[[Myelodysplastic syndrome|MD]]''}} | ||
| Line 121: | Line 123: | ||
* [[Chromosome 5q deletion syndrome]] | * [[Chromosome 5q deletion syndrome]] | ||
* [[Sideroblastic anemia]] | * [[Sideroblastic anemia]] | ||
* [[Paroxysmal nocturnal | * [[Paroxysmal nocturnal hemoglobinuria]] | ||
* [[Refractory cytopenia with multilineage dysplasia]] | * [[Refractory cytopenia with multilineage dysplasia]] | ||
| Line 136: | Line 138: | ||
* [[Mastocytosis|Systemic mastocytosis]] | * [[Mastocytosis|Systemic mastocytosis]] | ||
| group2 = {{nobold|[[Mastocytosis]]}} | | group2 = {{nobold|[[Mastocytosis]]:}} | ||
| list2 = | | list2 = | ||
* [[Diffuse cutaneous mastocytosis]] | * [[Diffuse cutaneous mastocytosis]] | ||
| Line 161: | Line 163: | ||
| group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}} | | group2 = {{nobold|''[[Myeloproliferative neoplasm|MP]]''}} | ||
| list2 = | | list2 = | ||
* [[ | * [[Myelofibrosis]] | ||
* [[ | * [[Acute biphenotypic leukaemia]] | ||
}} | }} | ||
}}<noinclude> | }}<noinclude> | ||
{{ | {{collapsible option}} | ||
[[Category:Oncology templates]] | |||
[[Category:Oncology | [[Category:Immunology templates]] | ||
[[Category:Immunology | </noinclude> | ||
{{no-index-template}} | |||
Latest revision as of 19:46, 8 March 2025
| Myeloid-related hematological malignancy | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|